ARX product is 20%-60% cheaper than other products on the market. And retains a 70% profit margin.
US is the largest market, and they are the new kids on the block. Sales growth will come over the next 18 months.
Looks attractively priced against it's peers.
News: ARX Aroa Biosurgery Posts FY22 Product Sales Guidance Of $30M-33M, page-12
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.8¢ |
Change
-0.003(0.42%) |
Mkt cap ! $205.6M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 61.0¢ | 58.0¢ | $80.65K | 134.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24656 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 13000 | 2 |
View Market Depth
| Last trade - 15.47pm 28/06/2024 (20 minute delay) ? |
| ARX (ASX) Chart |